HRP2 and HRP3 and the Performance of Diagnostic Tests for Malaria
*Corresponding Author:
Copyright: © 2021 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
As mentioned in the recently published article, currently, there is little evidence to document the true extent of HRP mutations worldwide. In countries where malaria is endemic, it is necessary to evaluate the genetic variability of the HRP2 and HRP3 genes in order to determine which mutations are present in each country with a view to improving the diagnosis and interpretation of the results obtained by Rapid Tests (RDT) and molecular factors, which could reduce the occurrence of false negatives and, in the medium and long term, improve malaria management programs and interventions [1].